000 01642 a2200433 4500
005 20250517135900.0
264 0 _c20170724
008 201707s 0 0 eng d
022 _a1873-5835
024 7 _a10.1016/j.leukres.2017.01.030
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQuagliano, Anthony
245 0 0 _aEpigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia.
_h[electronic resource]
260 _bLeukemia research
_c05 2017
300 _a36-43 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAzacitidine
_xpharmacology
650 0 4 _aCoculture Techniques
650 0 4 _aDNA Modification Methylases
_xantagonists & inhibitors
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aEpigenesis, Genetic
_xdrug effects
650 0 4 _aHeterografts
650 0 4 _aHistone Deacetylase Inhibitors
650 0 4 _aHumans
650 0 4 _aHydroxamic Acids
_xpharmacology
650 0 4 _aIndoles
_xpharmacology
650 0 4 _aMice
650 0 4 _aOsteoblasts
_xpathology
650 0 4 _aPanobinostat
650 0 4 _aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aTumor Cells, Cultured
700 1 _aGopalakrishnapillai, Anilkumar
700 1 _aBarwe, Sonali P
773 0 _tLeukemia research
_gvol. 56
_gp. 36-43
856 4 0 _uhttps://doi.org/10.1016/j.leukres.2017.01.030
_zAvailable from publisher's website
999 _c26858791
_d26858791